|
POLR2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.24110000054856E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.96530000554185E-08 |
| Normal-vs-Stage2 |
4.06699999999649E-06 |
| Normal-vs-Stage3 |
7.996700E-04 |
| Normal-vs-Stage4 |
3.65670000002094E-06 |
| Stage1-vs-Stage2 |
7.157200E-01 |
| Stage1-vs-Stage3 |
6.028400E-01 |
| Stage1-vs-Stage4 |
2.539200E-01 |
| Stage2-vs-Stage3 |
4.848000E-01 |
| Stage2-vs-Stage4 |
3.470000E-01 |
| Stage3-vs-Stage4 |
1.937000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63409999975883E-08 |
| Normal-vs-AfricanAmerican |
4.41229999981196E-07 |
| Normal-vs-Asian |
2.981300E-03 |
| Caucasian-vs-AfricanAmerican |
9.772800E-01 |
| Caucasian-vs-Asian |
8.643600E-01 |
| AfricanAmerican-vs-Asian |
8.392400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.92129986867451E-10 |
| Normal-vs-Female |
9.180700E-04 |
| Male-vs-Female |
5.319800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.59209999999188E-05 |
| Normal-vs-Extreme_Weight |
9.56280055142145E-10 |
| Normal-vs-Obese |
3.1430000002608E-07 |
| Normal-vs-Extreme_Obese |
3.236700E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.799000E-01 |
| Normal_Weight-vs-Obese |
7.620600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.094000E-01 |
| Extreme_Weight-vs-Obese |
1.390230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.037800E-01 |
| Obese-vs-Extreme_Obese |
5.922400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.786400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.87429999998212E-06 |
| Normal-vs-Age(61-80Yrs) |
1.11529999680116E-08 |
| Normal-vs-Age(81-100Yrs) |
1.91070000044036E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.718400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.970800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.420200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.377700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.031700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.845240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.63489999713573E-08 |
| Normal-VS-Type2 PRCC |
5.05289999841452E-08 |
| Normal-VS-KIRP CIMP |
1.637420E-04 |
| Normal-VS-Unclassified PRCC |
2.942300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.528600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.126600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.716500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.347800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.173900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.409200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.03160000541891E-08 |
| Normal-vs-N1 |
4.42470000000528E-05 |
| Normal-vs-N2 |
8.5153994966447E-11 |
| N0-vs-N1 |
3.153800E-01 |
| N0-vs-N2 |
4.281600E-01 |
| N1-vs-N2 |
8.988400E-02 |
|
|
